desvenlafaxine succinate

FDA Drug Profile — Pristiq Extended-Release, desvenlafaxine

desvenlafaxine succinate is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand names including Pristiq Extended-Release, desvenlafaxine. Available dosage forms: tablet, extended release, powder.

Drug details

Generic Name
desvenlafaxine succinate
Brand Names
Pristiq Extended-Release, desvenlafaxine
Application Number
NDA021992
Sponsor
Wyeth Pharmaceuticals LLC, A Subsidiary Of Pfizer Inc.
NDC Codes
8
Dosage Forms
TABLET, EXTENDED RELEASE, POWDER
Routes
ORAL
Active Ingredients
DESVENLAFAXINE SUCCINATE

Indications and Usage

1 INDICATIONS AND USAGE Desvenlafaxine is indicated for the treatment of adults with major depressive disorder (MDD) [see Clinical Studies (14)] . Desvenlafaxine is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with major depressive disorder (MDD) ( 1 ).

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.